These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35890117)

  • 1. Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review.
    Skokou M; Karavia EA; Drakou Z; Konstantinopoulou V; Kavakioti CA; Gourzis P; Kypreos KE; Andreopoulou O
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.
    De Berardis D; Rapini G; Olivieri L; Di Nicola D; Tomasetti C; Valchera A; Fornaro M; Di Fabio F; Perna G; Di Nicola M; Serafini G; Carano A; Pompili M; Vellante F; Orsolini L; Martinotti G; Di Giannantonio M
    Ther Adv Drug Saf; 2018 May; 9(5):237-256. PubMed ID: 29796248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development and implementation of clozapine protocol in patients with schizophrenia in Greece].
    Nystazaki M; Karanikola M; Gartzoni V; Georgou A; Tolia S; Liapis C; Psomiadi M; Alevizopoulos G
    Psychiatriki; 2020; 31(1):70-81. PubMed ID: 32544078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
    Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
    Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
    Manu P; Lapitskaya Y; Shaikh A; Nielsen J
    Am J Ther; 2018; 25(2):e218-e223. PubMed ID: 29505490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine treatment: Ensuring ongoing monitoring during the COVID-19 pandemic.
    Nystazaki M; Alevizopoulos G
    Psychiatriki; 2021 Jul; 32(2):165-166. PubMed ID: 33759812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the adverse effects of clozapine.
    Young CR; Bowers MB; Mazure CM
    Schizophr Bull; 1998; 24(3):381-90. PubMed ID: 9718630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine: is now the time for more clinicians to adopt this orphan?
    Stahl SM
    CNS Spectr; 2014 Aug; 19(4):279-81. PubMed ID: 25267329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guide to the Management of Clozapine-Related Tolerability and Safety Concerns.
    Citrome L; McEvoy JP; Saklad SR
    Clin Schizophr Relat Psychoses; 2016; 10(3):163-177. PubMed ID: 27732102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
    Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
    Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does clozapine cause or worsen obsessive compulsive symptoms? An analysis and literature review.
    Bleakley S; Brown D; Taylor D
    Ther Adv Psychopharmacol; 2011 Dec; 1(6):181-8. PubMed ID: 23983945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study.
    Lind PA; Parker RK; Northwood K; Siskind DJ; Medland SE
    Schizophr Bull; 2024 May; ():. PubMed ID: 38713070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis.
    Chen SY; Ravindran G; Zhang Q; Kisely S; Siskind D
    CNS Drugs; 2019 Mar; 33(3):225-238. PubMed ID: 30758782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy.
    Siskind D; Sidhu A; Cross J; Chua YT; Myles N; Cohen D; Kisely S
    Aust N Z J Psychiatry; 2020 May; 54(5):467-481. PubMed ID: 31957459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine safety, 35 years later.
    Raja M
    Curr Drug Saf; 2011 Jul; 6(3):164-84. PubMed ID: 22122392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.
    Manu P; Sarpal D; Muir O; Kane JM; Correll CU
    Schizophr Res; 2012 Feb; 134(2-3):180-6. PubMed ID: 22113154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.
    Ittasakul P; Archer A; Kezman J; Atsariyasing W; Goldman MB
    Clin Schizophr Relat Psychoses; 2016; 10(2):120-2. PubMed ID: 27440213
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.